News | May 29, 2024
Lilly increases manufacturing investment to US$ 9 billion at newest Indiana site
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
CiplaMed 2.0 leverages advanced analytics and automation
DeltaV control system natively integrated into Sartorius Biostat STR bioreactors provide a foundation for semi-autonomous operations and up to 80% less integration time
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
Subscribe To Our Newsletter & Stay Updated
